av Kristofer | 17 november, 2023
MyCural Therapeutics are developing cancer therapies for patients with aggressive high-risk tumors.
av Kristofer | 7 november, 2023
Zymego hjälper sjukvården att nå full kapacitet – genom automatisering. Fyller tomma tider Optimerar bokningsprocesser Minskar administration
av Henrik | 9 oktober, 2023
Suturion is bringing a new gold standard to the market for abdominal wall closure and an easier and improved way of working. Suture-TOOL has been developed for swift and standardized abdominal wall closure. The technology is developed from a clinical need and...
av Henrik | 9 oktober, 2023
Iscaffpharma’s mission is to establish the scaffold technology as gold standard for cancer drug development and develop own successful treatments for aggressive cancer. We use a new technology with human and 3D printed scaffolds that mimic true human environment...
av Henrik | 9 oktober, 2023
Abarceo Pharma, ett bolag i pre-klinisk fas som utvecklar en plattform för behandling av mitrokondiska sjukdomar med initialt fokus på typ-2 diabetes (T2D). Läs mer på hemsidan
